Hikma Pharmaceuticals (HIK)
HIK Share PerformanceMore
|52 week high||2,346.0 16/03/17|
|52 week low||1,101.0 17/08/17|
|52 week change||-1,095.0 (-47.36%)|
|4 week volume||19,954,887 28/07/17|
Latest News« previous» nextMore
22/08/2017 - 09:20 StockMarketWire
Goldman Sachs today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy...
22/08/2017 - 08:58 Interactive Investor
It's likely private investors are eyeing this mid cap up but sitting on their hands for now. This could be of interest to vigilan...
21/08/2017 - 10:27 StockMarketWire
Peel Hunt has cut its earnings by 30% for Hikma Pharma (LON:HIK), while the price target falls to 13.90 from 21.50. The do...
21/08/2017 - 10:20 StockMarketWire
Morgan Stanley today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to equal weight (from...
21/08/2017 - 08:50 StockMarketWire
Jefferies International today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its p...
21/08/2017 - 08:00 StockMarketWire
Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target t...
17/08/2017 - 16:49 StockMarketWire
Financial stocks continued to weigh on the FTSE 100, down 0.6% at 7,387. Standard Chartered (STAN) declined 2.7% to 755p...
17/08/2017 - 13:03 Interactive Investor
This FTSE 250 pharma has seen half its value wiped off in just five months. But Graeme Evans finds one positive analyst ...
|Dividend yield||2.712 %|
Latest discussion posts More
“Yes they can charge what they like, BUT the healthcare insurance companies can direct that a much cheaper alternative is used/supplied. The price hike strategy can backfire ...”▼
“Are they allowed to raise prices 430% This seems excessive.”▼
“Hikma?s US unit sharply raises prices of several drugs West-Ward increase cost of medicines by as much as 430% Hikma, the London-listed generic drugmaker, has sharply ...”▼
Codes & Symbols
|Symbols||HIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK|